We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+2.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.4B
AUM Growth
+$1.55B
(+3.4%)
Cap. Flow
-$454M
Cap. Flow
% of AUM
-0.96%
Top 10 Holdings %
Top 10 Hldgs %
21.97%
Holding
1,164
New
118
Increased
281
Reduced
356
Closed
129
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$485M |
| 2 |
Signet Jewelers
SIG
|
+$418M |
| 3 |
Skyworks Solutions
SWKS
|
+$325M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$324M |
| 5 |
Crown Holdings
CCK
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$321M |
| 2 |
GXP
Great Plains Energy Incorporated
GXP
|
+$299M |
| 3 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
+$198M |
| 4 |
Pfizer
PFE
|
+$171M |
| 5 |
K
Kellanova
K
|
+$165M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 15.61% |
| 2 | Healthcare | 15.04% |
| 3 | Technology | 12.55% |
| 4 | Industrials | 12.54% |
| 5 | Financials | 11.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Nike
NKE
$63.8B
| $7.83M | 0.02% |
141,872
-129,731
| -48% | -$7.39M |
|
377
Emerson Electric
EMR
$84.5B
| $7.81M | 0.02% |
149,672
+223
| +0.1% | +$11.8K |
|
378
Jones Lang LaSalle
JLL
$15.9B
| $7.78M | 0.02% |
79,801
+14,201
| +22% | +$1.63M |
|
379
General Dynamics
GD
$106B
| $7.63M | 0.02% |
54,841
+22,391
| +69% | +$3.12M |
|
380
Chubb
CB
$141B
| $7.63M | 0.02% |
58,351
-13,925
| -19% | -$1.72M |
|
381
VF Corp
VFC
$6.92B
| $7.55M | 0.02% |
130,449
+13,163
| +11% | +$779K |
|
382
Telefônica Brasil
VIV
$21.2B
| $7.54M | 0.02% |
+554,696
| New | +$6.68M |
|
383
Generac Holdings
GNRC
$11.2B
| $7.47M | 0.02% |
213,703
-33,965
| -14% | -$1.25M |
|
384
Waters Corp
WAT
$37B
| $7.43M | 0.02% |
52,871
+2,893
| +6% | +$391K |
|
|
SUPV
385
Grupo Supervielle
SUPV
$826M
| $7.43M | 0.02% |
+581,300
| New | +$6.97M |
|
|
TTF
386
DELISTED
Thai Fund
TTF
| $7.39M | 0.02% |
933,764
-11,245
| -1% | -$85.1K |
|
|
LDF
387
DELISTED
Latin American Discovery Fund
LDF
| $7.33M | 0.02% |
793,296
-1,535
| -0.2% | -$13.5K |
|
|
CLLS
388
Cellectis
CLLS
$282M
| $7.32M | 0.02% |
275,349
+16,286
| +6% | +$477K |
|
389
iShares MSCI Europe Small-Cap ETF
IEUS
$177M
| $7.31M | 0.02% |
175,685
-770
| -0.4% | -$34.6K |
|
|
SGF
390
DELISTED
Aberdeen Singapore Fund
SGF
| $7.28M | 0.02% |
804,787
-11,978
| -1% | -$107K |
|
391
Motorola Solutions
MSI
$72.4B
| $7.12M | 0.02% |
107,982
+4,187
| +4% | +$298K |
|
392
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
| – | – |
0
| – | – |
|
393
Toro Company
TTC
$9.15B
| $6.99M | 0.01% |
158,602
-212,544
| -57% | -$9.28M |
|
|
MXE
394
Mexico Equity and Income Fund
MXE
$58.5M
| $6.99M | 0.01% |
641,806
-22,631
| -3% | -$248K |
|
395
Gabelli Dividend & Income Trust
GDV
$2.61B
| $6.95M | 0.01% |
363,440
-361,817
| -50% | -$6.77M |
|
|
PTLA
396
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $6.88M | 0.01% |
291,763
+155,863
| +115% | +$3.85M |
|
397
Matador Resources
MTDR
$5.87B
| $6.77M | 0.01% |
341,919
-73,311
| -18% | -$1.58M |
|
|
COL
398
DELISTED
Rockwell Collins
COL
| $6.76M | 0.01% |
79,476
+4,339
| +6% | +$387K |
|
|
IMS
399
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $6.71M | 0.01% |
264,825
| – | – |
|
400
Elevance Health
ELV
$81.4B
| $6.68M | 0.01% |
50,855
+50
| +0.1% | +$6.84K |
|
Similar funds
QCM
Lazard Asset Management's Q2 2016 Portfolio in Review
As of Q2 2016, Lazard Asset Management held 1,164 positions worth $47.4B, up 3.4% from $45.8B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Lazard Asset Management's Q2 2016 filing shows 118 new, 281 increased, 356 reduced and 129 closed positions. Its largest new stake was Crown Holdings: 5,754,541 shares worth $292M. The largest sale was Apple, an estimated $321M.
By sector, the portfolio is most concentrated in Communication Services at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.
- Lazard Asset Management's largest Q2 2016 buy was Crown Holdings: 5,754,541 shares worth $292M.
- Lazard Asset Management added most to Allergan plc in Q2 2016, an estimated $485M increase.
- Lazard Asset Management's biggest Q2 2016 reduction was Apple, cutting an estimated $321M.
- Lazard Asset Management fully exited APA Corp in Q2 2016, selling an estimated $65M.
- Lazard Asset Management's ten largest holdings make up 22% of its $47.4B portfolio in Q2 2016.
- Lazard Asset Management opened 118 new positions and closed 129 in Q2 2016.
- Lazard Asset Management's portfolio value rose 3.4% quarter-over-quarter to $47.4B.
Based on Lazard Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.